Astellas Targets Glenmark Over Eczema Drug
Two subsidiaries of Japanese drugmaker Astellas Pharma Inc. have sued India's Glenmark Pharmaceuticals Ltd., seeking to put a halt to the generics maker's plan to produce its own version of eczema...To view the full article, register now.
Already a subscriber? Click here to view full article